---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-263477"
form_type: "8-K"
ticker: "VRCA"
cik: "0001660334"
company_name: "Verrica Pharmaceuticals Inc."
filed_at: "2024-11-21T23:59:59+00:00"
generated_at: "2026-05-29T20:51:59.732397+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Verrica prices $42M public offering of common stock and warrants at $0.89/unit

## Summary
- Raised ~$42M gross from 44.96M common shares, 2.24M pre-funded warrants, and 47.2M Series A/B warrants at $0.89/unit.
- Series A warrants exercisable at $1.068/sh, expire 1 year; Series B at $1.335/sh, expire 5 years.
- Offering expected to close Nov 22, 2024; Jefferies sole bookrunner with 30-day option for up to 7.08M additional shares.
- Pre-funded warrants have $0.0001 exercise price and 9.99% beneficial ownership limitation.

## SEC filing metadata
- accession: 0001193125-24-263477
- form_type: 8-K
- ticker: VRCA
- cik: 0001660334
- company_name: Verrica Pharmaceuticals Inc.
- filed_at: 2024-11-21T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1660334/000119312524263477/0001193125-24-263477-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1660334/000119312524263477/d769920d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-263477
- JSON: https://secwatch.observer/filing/0001193125-24-263477.json
- Plain text: https://secwatch.observer/filing/0001193125-24-263477.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.